Icen, H.Sekin, S.Simsek, A.Kochan, A.Tunik, S.2024-04-242024-04-2420111683-9919https://doi.org/10.3923/ajava.2011.744.749https://hdl.handle.net/11468/19408The aim of this study was to investigate the effects of Tarantula cubensis extract (Theranekron, Richter Pharma, Austria) applied on canine oral papillomatosis. A total of 10 dogs brought from dogs shelter to the Faculty of Veterinary Medicine, University of Dicle Turkey and aged between 7 and 36 months were used in this study. Diagnosis of the papillomatosis was based on clinical signs and histopathological examinations. Each dog received 2 mL per 10 kg of Tarantula cubensis extract subcutaneously two times per week. Regression of papillomas was observed after the beginning of treatment in second week. At the end of the third week 7 dogs recovered. The treatment continued on 3 dogs for two more weeks after which there was complete resolution of the lesion. Tarantula cubensis extract applications therefore seemed to be effective in the treatment of canine oral papillomatosis.eninfo:eu-repo/semantics/openAccessOral PapillomatosisTheranekronCanineHomepathyThe Efficacy of Tarantula cubensis Extract (Theranekron) in Treatment of Canine Oral PapillomatosisThe Efficacy of Tarantula cubensis Extract (Theranekron) in Treatment of Canine Oral PapillomatosisArticle67744749WOS:0002946522000112-s2.0-7995933660510.3923/ajava.2011.744.749N/AQ2